Neonatal Respiratory Distress Syndrome Treatment Market Size Share Trends Forecast 2027

1. NEONATAL RESPIRATORY DISTRESS SYNDROME TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Neonatal Respiratory Distress Syndrome Treatment Market - Overview Neonatal Respiratory Distress Syndrome Treatment Market-Regional Analysis. Among regions, the global Neonatal Respiratory Distress Syndrome Treatment Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In North America, U.S. holds a dominant position in the neonatal respiratory distress syndrome treatment market due to higher prevalence of neonatal respiratory distress syndrome in the country. According to the U.S National Library of Medicine, In 2014 to 2016 around 12% of the babies born in the U.S. Are suffering from neonatal respiratory distress syndrome. Pharmaceutical companies are focusing on strategies such as mergers and acquisitions due to high growth opportunities in the neonatal distress syndrome market. For instance, in 2018, Windtree Therapeutics and CVie Therapeutics announced their merger which was named Windtree Therapeutics. Through this merger, under the name of Windtree Therapeutics, will be fully integrated and diversified acute care company with four mid late clinical stage products including Aerosurf. Neonatal respiratory distress syndrome is also called surfactant deficiency disorder. Neonatal respiratory distress syndrome occurs in pre-mature infants due to insufficient development of pulmonary surfactant or structural immaturity of the lungs. Neonatal respiratory distress syndrome is manifested by fast breathing, chest-wall retraction, and grunting shortly after birth. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/neonatal-respiratory-distress-syndrome-treatment-market-4074 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Neonatal Respiratory Distress Syndrome Treatment Market - Drivers The increasing prevalence of neonatal respiratory distress syndrome is expected to facilitate the market growth. According to the U.S National Library of Medicine, in 2015, neonatal respiratory distress syndrome was found in 6 to 7% neonates in the U.S. Therefore, there is potential opportunity for pharmaceutical companies to expand their presence in the neonatal respiratory distress syndrome treatment market. Thus, pharmaceutical companies are focusing on mergers and acquisitions to achieve growth and make profits in neonatal respiratory distress syndrome treatment market. For instance, in 2017, Aerogan Pharmaceuticals and Lyomark Pharmaceuticals merged with the aim of developing AP-002, a clinically superior treatment for neonatal respiratory distress syndrome. These factors are expected to drive the neonatal respiratory distress syndrome treatment market growth. Neonatal Respiratory Distress Syndrome Treatment Market - Impact of COVID-19 Patients with respiratory distress syndrome are at severe risk of COVID-19. Whereas, in case neonates with respiratory distress syndrome are at minimal risk due to COVID-19 compared to adults due to less chance of community transmission. However, there is a chance of getting infected in the womb or due to close contact with an infected adult. On the other hand, surfactant therapy and mechanical ventilation are some of the efficient treatments for neonatal distress syndrome in COVID-19 patients. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4074 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Moreover, the market in Europe is expected to witness significant growth due to the increasing awareness about neonatal respiratory distress syndrome. Pharmaceutical companies are focusing on research and development activities which is favouring growth of the neonatal respiratory distress syndrome market. For instance, in 2017, Chiesi Farmaceutici S.p.A sponsored Saint Mary hospital research unit to carry out the 'CURONEB' study which involved investigation of safety, tolerability and efficiency of inhaled nebulized Curosurf used in the treatment of neonatal respiratory distress syndrome. Furthermore, Asia Pacific is expected to have significant growth, as well as advancements in medical devices which are supporting the growth of the market in this region. For instance, in 2019, InnAccel Technologies Pvt Ltd. (India) launched SAANS: portable neonatal CPAP device for infants with respiratory distress syndrome. SAANS is the only CPAP device with multiple power options, including a patented manual mode. Neonatal Respiratory Distress Syndrome Treatment Market- Competitive Landscape. Key players operating in neonatal respiratory distress syndrome treatment market are Chiesi Farmaceutici S.P.A, JW pharmaceuticals, Aragon Pharmaceuticals Inc, Lyomark Pharma GmbH, Takeda Pharmaceutical Company Limited, Menzies Institute for Medical Research, InnAccel Technologies Pvt Ltd, and Windtree Therapeutics, Inc. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4074 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved